Given the importance of developing better treatments for patients with KRAS driven tumours, non-toxic combinations with VitC are also being explored and will be discussed in the following section 2
Moreover, pretreatment with gemcitabine, a DNA-damaging agent, significantly enhances the cytotoxicity of BRAF inhibitors against resistant melanoma, pancreatic cancer and non-small cell lung cancer cells (130)
This high-potency formulation targets collagen synthesis, cellular migration, antimicrobial pathways, and genomic modulation simultaneously
Your safety protocols should include periodic bloodwork, and B12 should be on that panel
Alternatively, we wanted to test the possible BP-lowering effect of ALC above and beyond that of available medications in everyday clinical practice, a context in which serum carnitine level is a parameter that cannot be considered routinely for selection of potential candidates for treatment
Nebeling L, Miraldi F, Shurin S, Lerner E